BioSapien Extends its Pre-Series A Funding Round to USD 7M

Biotech startup BioSapien has successfully extended its pre-Series A funding round to $7 million. Global Ventures collaborated with Dara Holding to lead this round supporting the company’s mission to transform cancer treatment through innovation.  BioSapien’s...